COM:THYROCARE
Thyrocare
- Stock
Last Close
969.70
22/11 06:09
Market Cap
34.26B
Beta: -
Volume Today
18.07K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 77.88M - | 90.42M - | 126.08M 39.44% | 157.73M 25.11% | 175.64M 11.35% | 193.50M 10.17% | 219.90M 13.64% | 239.45M 8.89% | 261M 9.00% | ||
average payables | 8.60M - | 14.30M - | 13.52M 5.52% | 9.20M 31.96% | 43.35M 371.45% | 146.85M 238.75% | 234.35M 59.58% | 207.70M 11.37% | 209.40M 0.82% | ||
average receivables | 145.54M - | 169.11M 16.19% | 93.11M 44.94% | 257.65M - | 716.20M 177.97% | 935.40M 30.61% | 902.45M 3.52% | ||||
book value per share | 42.08 - | 55.50 31.88% | 71.03 27.99% | 75.91 6.86% | 82.51 8.70% | 81.50 1.22% | 69.43 14.81% | 80.85 16.44% | 99.56 23.15% | 100.97 1.41% | |
capex per share | -3.37 - | -2.02 40.00% | -2.80 38.73% | -6.79 142.20% | -8.12 19.74% | -7.54 7.21% | -1.87 75.13% | -5.35 185.23% | -7.15 33.77% | -8.25 15.32% | |
capex to depreciation | -2.31 - | -0.78 66.37% | -0.79 1.77% | -2.01 154.83% | -2.17 7.78% | -1.54 29.18% | -0.31 79.83% | -0.93 200.82% | -1.12 19.68% | -1.13 0.96% | |
capex to operating cash flow | -0.32 - | -0.29 8.78% | -0.21 26.66% | -0.41 91.15% | -0.41 0.32% | -0.40 1.61% | -0.06 85.28% | -0.24 312.40% | -0.33 36.96% | -0.34 1.20% | |
capex to revenue | -0.10 - | -0.05 44.17% | -0.06 9.54% | -0.12 98.05% | -0.12 3.36% | -0.10 18.45% | -0.02 77.12% | -0.06 150.01% | -0.06 12.44% | -0.08 29.01% | |
cash per share | 25.94 - | 18.06 30.39% | 19.80 9.66% | 21.10 6.55% | 20.85 1.18% | 15.78 24.33% | 15.17 3.89% | 22.75 49.99% | 26.25 15.41% | 29.26 11.45% | |
days of inventory on hand | 57.14 - | 46.11 19.31% | 53.17 15.32% | 59.24 11.41% | 65.52 10.60% | 59.71 8.87% | 64.28 7.66% | 52.02 19.07% | 52.76 1.43% | 61.87 17.26% | |
days payables outstanding | 9.89 - | 5.24 47.00% | 10.04 91.67% | 2.77 72.37% | 4.46 60.69% | 24.80 456.29% | 68.14 174.77% | 55.70 18.27% | 35.56 36.16% | 56.69 59.43% | |
days sales outstanding | 27.75 - | 23.02 17.03% | 22.15 3.78% | 43.42 - | 67.68 55.87% | 59.11 12.65% | 58.99 0.21% | ||||
debt to assets | 0.10 - | 0.02 - | 0.01 76.26% | 0.03 403.31% | 0.02 41.31% | 0.03 119.00% | 0.04 8.15% | ||||
debt to equity | 0.14 - | 0.02 - | 0.01 76.03% | 0.03 490.51% | 0.02 41.43% | 0.04 97.84% | 0.04 10.98% | ||||
dividend yield | 0.01 - | 0.01 59.30% | 0.01 14.28% | 0.02 59.95% | 0.01 43.09% | 0.05 427.71% | 0.01 77.99% | 0.02 74.62% | 0.03 80.38% | ||
earnings yield | 0.02 - | 0.01 14.64% | 0.02 11.55% | 0.02 10.46% | 0.03 57.68% | 0.03 3.91% | 0.03 11.54% | 0.02 29.65% | 0.04 81.10% | 0.03 34.00% | |
enterprise value | 26.20B - | 29.77B 13.65% | 30.91B 3.83% | 38.35B 24.06% | 32.07B 16.37% | 28.14B 12.25% | 26.26B 6.69% | 47.66B 81.48% | 41.08B 13.81% | 22.80B 44.49% | |
enterprise value over ebitda | 38.00 - | 40.61 6.85% | 32.17 20.78% | 32.85 2.13% | 20.52 37.54% | 17.63 14.06% | 14.93 15.36% | 27.37 83.39% | 17.32 36.74% | 17.59 1.57% | |
ev to operating cash flow | 56.65 - | 86.38 52.47% | 45.59 47.22% | 42.88 5.96% | 29.97 30.11% | 28.06 6.37% | 15.67 44.16% | 41.07 162.18% | 36.22 11.82% | 17.63 51.31% | |
ev to sales | 17.44 - | 16.27 6.68% | 12.83 21.17% | 12.50 2.56% | 9.00 27.99% | 6.98 22.40% | 6.06 13.21% | 9.63 58.94% | 6.98 27.60% | 4.33 37.93% | |
free cash flow per share | 7.22 - | 4.94 31.53% | 10.37 109.74% | 9.91 4.49% | 11.80 19.11% | 11.25 4.64% | 29.87 165.49% | 16.61 44.40% | 14.29 13.95% | 16.19 13.27% | |
free cash flow yield | 0.01 - | 0.01 31.53% | 0.02 109.74% | 0.01 19.82% | 0.02 43.24% | 0.02 7.87% | 0.06 182.09% | 0.02 69.41% | 0.02 0.18% | 0.04 104.31% | |
graham net net | 17.91 - | 17.09 4.54% | 14.50 15.19% | 19.64 35.49% | 15.79 19.59% | 10.05 36.34% | 4.99 50.32% | 15.55 211.25% | 26.76 72.15% | 25.51 4.67% | |
graham number | 100.04 - | 106.14 6.10% | 126.83 19.49% | 150.39 18.58% | 179.54 19.38% | 171.01 4.75% | 161.72 5.43% | 197.34 22.03% | 273.14 38.41% | 166.39 39.08% | |
income quality | 1.00 - | 0.52 48.29% | 0.83 60.00% | 0.82 1.37% | 0.74 9.70% | 0.73 1.57% | 1.14 57.50% | 0.76 33.53% | 0.50 34.58% | 1.48 197.28% | |
intangibles to total assets | 0.00 - | 0.14 3,928.93% | 0.26 87.39% | 0.25 6.53% | 0.23 8.12% | 0.23 0.86% | 0.22 5.45% | 0.19 14.17% | 0.17 10.30% | 0.16 4.00% | |
interest coverage | 290.51 - | 209.98 27.72% | 77.85 62.92% | 165.31 112.33% | 85.80 48.10% | 38.70 54.90% | |||||
interest debt per share | 5.72 - | 2.06 - | 0.58 71.70% | 2.71 364.51% | 1.77 34.55% | 4.36 146.30% | 4.85 11.16% | ||||
inventory turnover | 6.39 - | 7.92 23.93% | 6.86 13.29% | 6.16 10.24% | 5.57 9.58% | 6.11 9.74% | 5.68 7.11% | 7.02 23.56% | 6.92 1.41% | 5.90 14.72% | |
invested capital | 0.14 - | 0.02 - | 0.01 76.03% | 0.03 490.51% | 0.02 41.43% | 0.04 97.84% | 0.04 10.98% | ||||
market cap | 26.32B - | 29.82B 13.33% | 31.02B 4.00% | 38.47B 24.02% | 32.06B 16.64% | 28.17B 12.16% | 26.22B 6.90% | 47.70B 81.91% | 41.00B 14.04% | 22.75B 44.53% | |
net current asset value | 892.82M - | 917.83M 2.80% | 903.39M 1.57% | 1.17B 29.85% | 1.07B 9.04% | 964.20M 9.63% | 495.80M 48.58% | 1.20B 141.25% | 1.89B 57.96% | 1.75B 7.14% | |
net debt to ebitda | -0.17 - | -0.07 59.91% | -0.11 54.78% | -0.10 7.33% | 0.01 105.18% | -0.02 393.56% | 0.02 240.77% | -0.03 227.27% | 0.03 210.17% | 0.04 43.37% | |
net income per share | 10.57 - | 9.02 14.64% | 10.06 11.55% | 13.24 31.58% | 17.36 31.11% | 15.95 8.15% | 16.74 4.98% | 21.41 27.88% | 33.30 55.56% | 12.19 63.41% | |
operating cash flow per share | 10.59 - | 6.96 34.23% | 13.17 89.15% | 16.69 26.71% | 19.92 19.36% | 18.79 5.69% | 31.74 68.94% | 21.95 30.84% | 21.44 2.33% | 24.44 13.96% | |
payables turnover | 36.92 - | 69.67 88.69% | 36.35 47.83% | 131.56 261.95% | 81.87 37.77% | 14.72 82.02% | 5.36 63.61% | 6.55 22.35% | 10.27 56.65% | 6.44 37.28% | |
receivables turnover | 13.15 - | 15.85 20.52% | 16.48 3.93% | 8.41 - | 5.39 35.85% | 6.17 14.48% | 6.19 0.21% | ||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.19 - | 0.16 16.34% | 0.17 8.93% | 0.22 25.84% | 0.25 16.49% | 0.23 7.67% | 0.24 3.36% | 0.25 5.91% | 0.35 36.62% | 0.12 65.12% | |
revenue per share | 34.40 - | 36.97 7.46% | 46.82 26.64% | 57.25 22.29% | 66.32 15.85% | 75.47 13.79% | 82.03 8.69% | 93.59 14.09% | 111.34 18.97% | 99.53 10.61% | |
roe | 0.25 - | 0.16 35.28% | 0.14 12.84% | 0.17 23.13% | 0.21 20.61% | 0.20 7.01% | 0.24 23.23% | 0.26 9.83% | 0.33 26.32% | 0.12 63.92% | |
roic | 0.20 - | 0.14 28.40% | 0.13 6.14% | 0.16 19.14% | 0.18 11.40% | 0.18 0.79% | 0.23 29.14% | 0.24 3.07% | 0.28 15.27% | 0.11 58.93% | |
sales general and administrative to revenue | 0.00 - | 0.02 4,895.50% | 0.03 11.50% | 0.03 0.59% | 0.03 18.69% | 0.04 27.88% | 0.04 14.41% | 0.03 23.83% | 0.03 9.35% | 0.04 50.21% | |
shareholders equity per share | 42.08 - | 55.50 31.88% | 71.03 27.99% | 75.91 6.86% | 82.51 8.70% | 81.50 1.22% | 69.43 14.81% | 80.85 16.44% | 99.56 23.15% | 100.97 1.41% | |
stock based compensation to revenue | 0.01 - | 0.00 40.22% | 0.00 0.19% | 0.00 3.62% | 0.00 26.43% | 0.00 15.99% | 0.04 920.25% | ||||
tangible asset value | 2.05B - | 2.64B 28.66% | 2.57B 2.56% | 2.99B 16.23% | 3.35B 11.84% | 3.27B 2.43% | 2.65B 18.79% | 3.26B 22.93% | 4.25B 30.50% | 4.34B 2.04% | |
tangible book value per share | 47.04 - | 62.77 33.46% | 71.03 13.16% | 55.85 21.38% | 62.31 11.56% | 61.18 1.81% | 50.22 17.91% | 61.69 22.83% | 80.44 30.40% | 82.04 1.99% | |
working capital | 1.22B - | 1.04B 15.10% | 1.03B 0.83% | 1.30B 26.13% | 1.22B 6.01% | 1.15B 5.47% | 705.60M 38.87% | 1.43B 102.71% | 2.06B 43.68% | 1.96B 4.70% |
All numbers in (except ratios and percentages)